Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2012 R33 RFA-CA-12-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS DISCOVERY OF DEATH LIGANDS AGAINST CANCERS Complete
2016 R21 RFA-CA-15-002 LARMAN, HARRY BENJAMIN JOHNS HOPKINS UNIVERSITY A HIGHLY MULTIPLEXED GENE EXPRESSION PLATFORM FOR FIXED TISSUE SPECIMENS Complete
2000 R21 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2002 R33 PAR-01-104 SPEICHER, DAVID W. WISTAR INSTITUTE DEVELOPMENT OF METHODS FOR CANCER BIOMARKER DETECTION Complete
2005 R21 RFA-CA-05-004 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATION Complete
2008 R21 RFA-CA-07-035 NOLTE, DAVID D PURDUE UNIVERSITY WEST LAFAYETTE MULTIPLEXED ASSAYS ON THE BIOCD FOR ACUTE LYMPHOCYTIC LEUKEMIA Complete
2011 R21 RFA-CA-10-005 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE TARGETING CANCER CELLS WITH FUNCTIONALIZED NANOPARTICLE LIBRARIES Complete
2015 R21 RFA-CA-14-005 KRUMMEL, MATTHEW F UNIVERSITY OF CALIFORNIA, SAN FRANCISCO LIVING TUMOR BIOPSIES TO INTERROGATE IMMUNE FUNCTION AND RESPONSE TO THERAPY Complete
1999 R43 PAR-98-066 HAGEN, FREDERICK S ICOGENEX CORPORATION AFFINITY AND TRANSCRIPTASE TECHNOLOGIES Complete
2001 R44 PAR-99-101 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2004 R44 PAR-01-105 BATTRELL, CHARLES FRED MICRONICS, INC. MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER Complete
2007 R42 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2010 R33 RFA-CA-09-005 WANG, SHAN X. STANFORD UNIVERSITY CANCER SAMPLE PREPARATION WITH MICROMACHINED MAGNETIC SIFTER AND NANOPARTICLES Complete
2014 R33 RFA-CA-13-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER ADVANCED METHODS TO EVALUATE EXTRACELLULAR MATRIX AND CROSSLINKING IN THE TUMOR M Complete
2017 R33 RFA-CA-16-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples Complete
1999 R21 PAR-98-067 STRAUSS, WILLIAM M BETH ISRAEL DEACONESS MEDICAL CENTER EVALUATION OF SEQUENCE SPECIFIC CHANGES IN GENOMIC DNA Complete
2001 R33 PAR-99-100 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS Complete
2003 R43 PAR-01-105 SCHNEIDER, LUKE V TARGET DISCOVERY IDBEST DIFFERENTIAL DISPLAY ON PROTEIN CHIPS Complete
2007 R21 RFA-CA-07-002 KAUFMAN, DAVID G. UNIV OF NORTH CAROLINA CHAPEL HILL IDENTIFICATION OF AREAS OF OXIDATIVE DAMAGE IN HUMAN GENOMIC DNA Complete
2009 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2013 R33 RFA-CA-12-005 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES MOLECULAR AND FUNCTIONAL ANALYSIS OF SINGLE CIRCULATING MELANOMA CELLS Complete
2000 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. PHARMACOGENOMICS OF CARCINOGENESIS IN WHOLE ANIMALS Complete
2002 R43 PAR-01-105 YANG, CHIHAE LEADSCOPE, INC. A NOVEL CHEMICAL GENOMICS METHODOLOGY Complete
2006 R21 RFA-CA-06-003 SHI, HUIDONG UNIVERSITY OF MISSOURI-COLUMBIA EPIGENETIC TARGETING IN NON-HODGKIN'S LYMPHOMA Complete
2009 R21 RFA-CA-08-006 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROASSAY SYSTEMS FOR DIAGNOSIS OF CANCER CELL MOTILITY AND METASTASIS Complete
2012 R33 RFA-CA-12-003 NOLLING, JORK N PRIMERADX, INC. A HIGHLY MULTIPLEXED PCR PLATFORM FOR GENE EXPRESSION PROFILING FROM FFPE TISSUE Complete
2016 R21 RFA-CA-15-002 LIANG, FU-SEN UNIVERSITY OF NEW MEXICO NOVEL BI-FUNCTIONAL INHIBITORS BLOCKING ONCOMIR BIOGENESIS Complete
2000 R21 PAR-99-100 CHEE, MARK S. ILLUMINA, INC. PROTEIN PROFILING ARRAYS Complete
2002 R33 PAR-01-106 SHAUGHNESSY, JOHN DAMIAN UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK MOLECULAR DIAGNOSIS AND PROGNOSIS OF MULTIPLE MYELOMA Complete
2005 R21 RFA-CA-05-004 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) DEVELOPMENT OF AN AUTOMATED FROZEN SAMPLE ALIQUOTTER Complete
2008 R21 RFA-CA-07-037 WONG, DAVID T UNIVERSITY OF CALIFORNIA LOS ANGELES COLLECTION, STABILIZATION AND STORAGE OF SALIVA SAMPLES FOR CANCER RESEARCH Complete
2011 R21 RFA-CA-10-005 CLARY, BRYAN M DUKE UNIVERSITY IN VIVO SELECTION OF TUMOR-SPECIFIC RNA BINDING MOTIFS Complete
2015 R33 RFA-CA-14-004 BURKE, PETER J. UNIVERSITY OF CALIFORNIA-IRVINE HIGH-THROUGHPUT ON-CHIP PLATFORM FOR INTERROGATION OF MITOCHONDRIAL MEMBRANE POTENTIAL AND APOPTOSIS Complete
1999 R43 PAR-98-066 GERDES, JOHN CHARLES XTRANA, INC. QUANTITATION AND ARCHIVING OF GENE EXPRESSION Complete
2001 R44 PAR-99-101 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2004 R44 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2007 R43 RFA-CA-07-010 BOGEN, STEVEN A MEDICAL DISCOVERY PARTNERS, LLC ISOLATION OF CIRCULATING TUMOR CELLS FROM PERIPHERAL BLOOD Complete
2010 R33 RFA-CA-09-007 BESTOR, TIMOTHY H COLUMBIA UNIVERSITY HEALTH SCIENCES MAMMARY CARCINOMA AND GENOMIC METHYLATION PATTERNS Complete
2014 R33 RFA-CA-13-004 NOLAN, GARRY P. STANFORD UNIVERSITY HIGHLY MULTIPLEXED ION-BEAM TISSUE MOLECULAR IMAGING WITH SUB-MICRON RESOLUTION Complete
2017 R33 RFA-CA-16-002 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer Complete
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma NCE
2017 R33 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes NCE
2017 R33 RFA-CA-16-002 IBRAHIM, YEHIA BATTELLE PACIFIC NORTHWEST LABORATORIES High Resolution High Throughput Proteomics Platform for Cancer Research NCE
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES NCE
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity NCE
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing NCE
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications NCE
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS NCE
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
2018 R21 RFA-CA-17-010 FIELDS, RYAN C WASHINGTON UNIVERSITY Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment NCE

Pages